ethyl methanesulfonate has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivarie, RD; Morris, JA | 1 |
| Ivarie, RD; Martial, JA; Morris, JA | 1 |
2 other study(ies) available for ethyl methanesulfonate and Pituitary Neoplasms
| Article | Year |
|---|---|
Induction of prolactin-deficient variants of GH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine, a DNA methylation inhibitor.
Topics: Animals; Azacitidine; Cell Line; Ethyl Methanesulfonate; Gene Expression Regulation; Methylation; Mutation; Phenotype; Pituitary Neoplasms; Prolactin; Rats; Ultraviolet Rays | 1982 |
Prolactin-deficient variants of GH3 rat pituitary tumor cells: linked expression of prolactin and another hormonally responsive protein in GH3 cells.
Topics: Alkylation; Animals; Cell Line; Clone Cells; Dexamethasone; DNA; Ethyl Methanesulfonate; Gene Expression Regulation; Mutation; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Protein Biosynthesis; Rats; RNA, Messenger | 1982 |